ISOFLEX USA/NUCMEDCOR
Website to be confirmed.
About ISOFLEX USA/NUCMEDCOR
ISOFLEX USA/NUCMEDCOR sits in Isotope Supply, a segment Bracken sees as structurally important to the radiopharma value chain.
Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.
What we're seeing
- Reuters Health · 2026-05-16Isoflex Usa Nucmedcor closes Series C round to scale radiopharma manufacturingDetails remain limited but analysts read the move as a positioning play ahead of pivotal data.
- Endpoints News · 2026-10-23Isoflex Usa Nucmedcor publishes dosimetry data at SNMMI 2026Coverage notes the company's growing footprint in the radioligand therapy space.
- FierceBiotech · 2026-11-02Isoflex Usa Nucmedcor files IND for next-generation PSMA-targeted agentIndustry observers expect more activity of this kind in the run-up to SNMMI 2026.
Mocked while we wire the Exa integration. Headlines are illustrative.
What we expect to see at the booth
Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.
A short Bracken POV will go here, drawing on our experience across this part of the radiopharma value chain. Specific commentary to be filled in by the team.
Editorial shown for exhibitors in Bracken's wheelhouse: radiopharma developers, isotope supply, CDMO/CMO, cyclotron, and imaging equipment.
Companies you may also want to visit.
ABX advanced biochemical compounds
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on ABX advanced biochemical compounds.
View profile →BWXT Medical Ltd.
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on BWXT Medical Ltd..
View profile →Eckert & Ziegler Isotope
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on Eckert & Ziegler Isotope.
View profile →